Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modulators of protein–protein interactions as antimicrobial agents
Rashi Kahan, Dennis J. Worm, Guilherme V. Castro, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 2, pp. 387-409
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Peptide design to control protein–protein interactions
Suzanne P. van Wier, Andrew M. Beekman
Chemical Society Reviews (2025)
Open Access | Times Cited: 4
De novo designed peptides for cellular delivery and subcellular localisation
Guto G. Rhys, Jessica A. Cross, William Dawson, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 9, pp. 999-1004
Open Access | Times Cited: 31
Anti-infective therapy using species-specific activators of Staphylococcus aureus ClpP
Bingyan Wei, Tao Zhang, Pengyu Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Engineering ribosomally synthesized and posttranslationally modified peptides as new antibiotics
Anna L. Vagstad
Current Opinion in Biotechnology (2023) Vol. 80, pp. 102891-102891
Open Access | Times Cited: 10
Three- and four-stranded nucleic acid structures and their ligands
Yoshiki Hashimoto, Sumit Shil, Mitsuki Tsuruta, et al.
RSC Chemical Biology (2025)
Open Access
Computer-Aided Drug Design: An Update
Wenbo Yu, David J. Weber, Alexander D. MacKerell
Methods in molecular biology (2022), pp. 123-152
Closed Access | Times Cited: 15
Inhibition of bacterial RNA polymerase function and protein–protein interactions: a promising approach for next-generation antibacterial therapeutics
Jiqing Ye, Cheuk Hei Kan, Xiao Yang, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1471-1487
Closed Access | Times Cited: 3
Peptide-Based Inhibitors of Protein–Protein Interactions (PPIs): A Case Study on the Interaction Between SARS-CoV-2 Spike Protein and Human Angiotensin-Converting Enzyme 2 (hACE2)
Aizhan Rakhmetullina, Piotr Zielenkiewicz, Norbert Odolczyk
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2361-2361
Open Access | Times Cited: 3
What is an ideal antibiotic and what does this mean for future drug discovery and design?
Stephanie Kate Sandiford
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 5, pp. 485-490
Open Access | Times Cited: 8
The battle within: how Pseudomonas aeruginosa uses host-pathogen interactions to infect the human lung
Carmen Mesas Vaz, Alba Guembe Mülberger, Marc Torrent
Critical Reviews in Microbiology (2024), pp. 1-36
Closed Access | Times Cited: 2
The DarT/DarG Toxin–Antitoxin ADP-Ribosylation System as a Novel Target for a Rational Design of Innovative Antimicrobial Strategies
Giuliana Catara, Rocco Caggiano, Luca Palazzo
Pathogens (2023) Vol. 12, Iss. 2, pp. 240-240
Open Access | Times Cited: 6
Methyltransferases from RiPP pathways: shaping the landscape of natural product chemistry
M. Schröder, I. Pfeiffer, Silja Mordhorst
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1652-1670
Open Access | Times Cited: 2
Analysis of Host–Bacteria Protein Interactions Reveals Conserved Domains and Motifs That Mediate Fundamental Infection Pathways
Jordi Gómez Borrego, Marc Torrent
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11489-11489
Open Access | Times Cited: 9
Iterative Structure-Based Optimization of Short Peptides Targeting the Bacterial Sliding Clamp
Clément Monsarrat, Guillaume Compain, Christophe André, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 17063-17078
Open Access | Times Cited: 11
Synthesis and biological evaluation of nusbiarylin derivatives as bacterial rRNA synthesis inhibitor with potent antimicrobial activity against MRSA and VRSA
Yangyi Qiu, Adrian Jun Chu, Tsz Fung Tsang, et al.
Bioorganic Chemistry (2022) Vol. 124, pp. 105863-105863
Open Access | Times Cited: 7
Sulfonamidyl derivatives of sigmacidin: Protein-protein interaction inhibitors targeting bacterial RNA polymerase and sigma factor interaction exhibiting antimicrobial activity against antibiotic-resistant bacteria
Jiqing Ye, Cheuk Hei Kan, Yingbo Zheng, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106983-106983
Closed Access | Times Cited: 4
Validation of aminodeoxychorismate synthase and anthranilate synthase as novel targets for bispecific antibiotics inhibiting conserved protein-protein interactions
Franziska Jasmin Funke, Sandra Schlee, Reinhard Sterner
Applied and Environmental Microbiology (2024) Vol. 90, Iss. 5
Closed Access | Times Cited: 1
QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against Streptococci
Jiqing Ye, Xiao Yang, Cong Ma
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4085-4085
Open Access | Times Cited: 6
Increasing the Scalability of Toxin–Intein Orthogonal Combinations
Rocío López‐Igual, Pedro Dorado‐Morales, Didier Mazel
ACS Synthetic Biology (2023) Vol. 12, Iss. 2, pp. 618-623
Open Access | Times Cited: 3
A cell-free strategy for host-specific profiling of intracellular antibiotic sensitivity and resistance
Kameshwari Chengan, Charlotte K. Hind, Maria Stanley, et al.
npj Antimicrobials and Resistance (2023) Vol. 1, Iss. 1
Open Access | Times Cited: 3
An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation
Alessia Caputo, Sara Sartini, Elisabetta Levati, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 5
Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics
Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, et al.
(2023), pp. 343-428
Closed Access | Times Cited: 1
Covalent Inhibition of a Host–Pathogen Protein–Protein Interaction Reduces the Infectivity of Streptococcus pneumoniae
Yuhan Lyu, Fan Yang, Bharathi Sundaresh, et al.
JACS Au (2024) Vol. 4, Iss. 7, pp. 2484-2491
Open Access
Characterization of the Key Determinants of Phd Antitoxin Mediated Doc Toxin Inactivation in Salmonella
Guilherme V. Castro, Dennis J. Worm, Grzegorz J. Grabe, et al.
ACS Chemical Biology (2022) Vol. 17, Iss. 6, pp. 1598-1606
Open Access | Times Cited: 1
A cell-free strategy for profiling intracellular antibiotic sensitivity and resistance
Kameshwari Chengan, Charlotte K. Hind, Lakshmeesha Kempaiah Nagappa, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1 - Next Page

Scroll to top